Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. is a listed company controlled by Guangzhou Pharmaceutical Group Co., Ltd. (A shares 600332, H shares 00874), mainly engaged in: (1) Chinese and Western patent medicines, chemical raw materials, natural medicines, biomedicine, and chemical raw materials. Research, development, manufacturing and sales of intermediates; (2) Wholesale, retail and import and export business of Western medicine, Chinese medicine and medical devices; (3) R&D, production and sales of big health products; and (4) Medical services and health management , health industry investments such as health preservation and elderly care. The main traditional Chinese medicine products include Xiaoxie Pills, Qingkailing Series, Xiasangju Granules Series, Huatuo Rezai Pills, Angong Niuhuang Pills, Wanglaoji Herbal Tea, Wanglaoji Children's Qixing Tea, Zhuifeng Tougu Pills, etc.; the main chemical products include cefosthamidine , cefixime, amoxicillin, sildenafil citrate, etc.; the main health products include Wanglaoji herbal tea, Ganoderma lucidum spore oil soft capsules, etc.
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. is a listed company controlled by Guangzhou Pharmaceutical Group Co., Ltd. (A shares 600332, H shares 00874), mainly engaged in: (1) Chinese and Western patent medicines, chemical raw materials, natural medicines, biomedicine, and chemical raw materials. Research, development, manufacturing and sales of intermediates; (2) Wholesale, retail and import and export business of Western medicine, Chinese medicine and medical devices; (3) R&D, production and sales of big health products; and (4) Medical services and health management , health industry investments such as health preservation and elderly care. The main traditional Chinese medicine products include Xiaoxie Pills, Qingkailing Series, Xiasangju Granules Series, Huatuo Rezai Pills, Angong Niuhuang Pills, Wanglaoji Herbal Tea, Wanglaoji Children's Qixing Tea, Zhuifeng Tougu Pills, etc.; the main chemical products include cefosthamidine , cefixime, amoxicillin, sildenafil citrate, etc.; the main health products include Wanglaoji herbal tea, Ganoderma lucidum spore oil soft capsules, etc.
Zhejiang Conba Pharmaceutical Co., Ltd.
Jiangxi Zhenshiming Pharmaceutical Co., Ltd. is located in Fuzhou City, Jiangxi Province, a "hometown of talented men" and a "cultural country" with a prosperous humanistic culture. Jiangxi Zhenshiming Pharmaceutical Co., Ltd. was formerly known as "Fuzhou Pharmaceutical Factory" and was founded in 1968. The company covers an area of 165 mu, with an investment of nearly 100 million yuan. It has been built into a new modern garden-style ophthalmology health enterprise with complete hardware facilities according to the GMP standard, specializing in the research, development, production and sales of eye health consumer products and medicines. It has now developed into a comprehensive company integrating pharmaceutical industry, medical devices, cosmetics, daily necessities production, research and development, sales and pharmaceutical retail. The company has 48 varieties mainly eye drops, 7 products entered the national basic medicine catalog and 25 national medical insurance products. Among them, the four flavors of Zhen Layer Ice Boron Eye Drops (Zhenshi Ming Eye Drops) were included in the National Pharmacopeia and were designated as the teenager's eye drops for myopia designated by the State Education Commission (Document No. 66 of the Education Department [1992]. The company has nearly 100 million yuan. A consumer group with students as the main force. Since 2012, the company has vigorously expanded its health consumer goods business and successfully developed and launched Zhenshiming steam eye masks, eye patches, eye washes and other products.
Zhejiang Conba Pharmaceutical Co., Ltd.
Jiangxi Zhenshiming Pharmaceutical Co., Ltd. is located in Fuzhou City, Jiangxi Province, a "hometown of talented men" and a "cultural country" with a prosperous humanistic culture. Jiangxi Zhenshiming Pharmaceutical Co., Ltd. was formerly known as "Fuzhou Pharmaceutical Factory" and was founded in 1968. The company covers an area of 165 mu, with an investment of nearly 100 million yuan. It has been built into a new modern garden-style ophthalmology health enterprise with complete hardware facilities according to the GMP standard, specializing in the research, development, production and sales of eye health consumer products and medicines. It has now developed into a comprehensive company integrating pharmaceutical industry, medical devices, cosmetics, daily necessities production, research and development, sales and pharmaceutical retail. The company has 48 varieties mainly eye drops, 7 products entered the national basic medicine catalog and 25 national medical insurance products. Among them, the four flavors of Zhen Layer Ice Boron Eye Drops (Zhenshi Ming Eye Drops) were included in the National Pharmacopeia and were designated as the teenager's eye drops for myopia designated by the State Education Commission (Document No. 66 of the Education Department [1992]. The company has nearly 100 million yuan. A consumer group with students as the main force. Since 2012, the company has vigorously expanded its health consumer goods business and successfully developed and launched Zhenshiming steam eye masks, eye patches, eye washes and other products.
Shenzhen Yibainian Investment Industrial Co., Ltd.
Shenzhen Yi Bonian Investment Sandwich Industry Co., Ltd. is a high-tech innovative enterprise focusing on the research and development, manufacturing, sales, and service of hydrogen health products. Focusing on the core of the big health industry, expanding human health, and serving the world are the goal pursued by the Yi Bonian people. The company has a core and high-quality R&D team, focusing on the development of software and hardware for hydrogen molecular health products. He is proficient in the R&D, design, and production of snow energy equipment products, and is committed to guiding the direction of hydrogen molecular products. With the responsibility of serving public health and the leading role of innovation and technology, we always pursue high-quality products and services. Provide customers with convenient and reliable services online and offline, public health, hydrogen pine realization, hydrogen care, and healthy life, so that hydrogen energy series products can benefit the public for a better life.
Shenzhen Yibainian Investment Industrial Co., Ltd.
Shenzhen Yi Bonian Investment Sandwich Industry Co., Ltd. is a high-tech innovative enterprise focusing on the research and development, manufacturing, sales, and service of hydrogen health products. Focusing on the core of the big health industry, expanding human health, and serving the world are the goal pursued by the Yi Bonian people. The company has a core and high-quality R&D team, focusing on the development of software and hardware for hydrogen molecular health products. He is proficient in the R&D, design, and production of snow energy equipment products, and is committed to guiding the direction of hydrogen molecular products. With the responsibility of serving public health and the leading role of innovation and technology, we always pursue high-quality products and services. Provide customers with convenient and reliable services online and offline, public health, hydrogen pine realization, hydrogen care, and healthy life, so that hydrogen energy series products can benefit the public for a better life.
Shandong Zhushi Pharmaceutical Group Co.,LTD
Shandong Zhushi Pharmaceutical Group is located in China. It has been in the industry of Medical Devices for over 20 years now.
Our company presents innovative products to you that including Medical Devices (Epidemic Prevention Products, Medical consumables, Medical Plaster & Medical Gel Products), Skin Care and Cosmetics, Health Food Products, etc.
Shandong Zhushi Pharmaceutical Group Co.,LTD
Shandong Zhushi Pharmaceutical Group is located in China. It has been in the industry of Medical Devices for over 20 years now.
Our company presents innovative products to you that including Medical Devices (Epidemic Prevention Products, Medical consumables, Medical Plaster & Medical Gel Products), Skin Care and Cosmetics, Health Food Products, etc.
Guilin Sanjin Pharmaceutical Co., Ltd.
Guilin Sanjin Pharmaceutical Co., Ltd. is the core enterprise of Sanjin Group. It mainly engages in the research and development and production of traditional Chinese medicine and natural medicines. It is one of the earliest manufacturers in China to produce modern Chinese medicine preparations. Since 1985, Guilin Sanjin has insisted on reform and innovation, relying on scientific and technological progress and scientific management, and has transformed from an unknown small traditional Chinese medicine workshop into a nationally renowned modern traditional Chinese medicine enterprise. As a well-known high-tech enterprise inside and outside the district, Sanjin has established innovative platforms such as nationally recognized enterprise technology centers, postdoctoral research workstations and Guangxi Institute of Traditional Chinese Medicine Industrialization Engineering. Over the years, we have been committed to promoting and implementing the modernization plan of the traditional Chinese medicine industry and actively cultivating and improving the independent innovation capabilities of enterprises. The company's new special Chinese medicines are all developed by the enterprise technology center. At present, Sanjin has more than 200 registered varieties and 13 pharmaceutical dosage forms, and has 42 special varieties independently developed by Guilin Watermelon Cream, Watermelon Cream Throat Soft Tablets, Sanjin Tablets, Naomaitai Capsules, etc. After years of hard work, Sanjin has formed strong professional and market advantages in throat, oral medication and urinary system medication. Its representative products, Sanjin Watermelon Cream Series and Sanjin Tablets, have been at the forefront of similar Chinese patent medicines in the country for many years. In July 2009, Guilin Sanjin successfully entered the capital market with a new look of high growth and high efficiency, and ushered in a new stage of rapid development of the enterprise. In recent years, in order to actively respond to the call of Guilin Municipal Party Committee and Municipal Government to "develop westward and create a new Guilin", and to resolve the contradiction between the dispersed production bases and warehousing facilities of enterprises and the rapid development of enterprises, Sanjin has launched the "Sanjin". The construction of the modern traditional Chinese medicine industrialization technology transformation project. At present, the first phase of the project has been officially put into production and the overall relocation of the main production lines has been achieved. Facing the future, Sanjin will uphold the corporate mission of "innovation to promote pharmaceutical progress" and the corporate spirit of "dare to be the first", implement the "one body and two wings" development strategy with traditional Chinese medicine as the main body and committed to developing biopharmaceuticals and the big health industry, Quality and reputation are the first life of the enterprise, breakthroughs and innovation, continuously enhances the competitive strength of Sanjin, and is enterprising, with the goal of developing to serve the country and repay investors, and with the goal of building China's advanced pharmaceutical manufacturing group, we will promote the modernization and internationalization of the traditional Chinese medicine industry!
Guilin Sanjin Pharmaceutical Co., Ltd.
Guilin Sanjin Pharmaceutical Co., Ltd. is the core enterprise of Sanjin Group. It mainly engages in the research and development and production of traditional Chinese medicine and natural medicines. It is one of the earliest manufacturers in China to produce modern Chinese medicine preparations. Since 1985, Guilin Sanjin has insisted on reform and innovation, relying on scientific and technological progress and scientific management, and has transformed from an unknown small traditional Chinese medicine workshop into a nationally renowned modern traditional Chinese medicine enterprise. As a well-known high-tech enterprise inside and outside the district, Sanjin has established innovative platforms such as nationally recognized enterprise technology centers, postdoctoral research workstations and Guangxi Institute of Traditional Chinese Medicine Industrialization Engineering. Over the years, we have been committed to promoting and implementing the modernization plan of the traditional Chinese medicine industry and actively cultivating and improving the independent innovation capabilities of enterprises. The company's new special Chinese medicines are all developed by the enterprise technology center. At present, Sanjin has more than 200 registered varieties and 13 pharmaceutical dosage forms, and has 42 special varieties independently developed by Guilin Watermelon Cream, Watermelon Cream Throat Soft Tablets, Sanjin Tablets, Naomaitai Capsules, etc. After years of hard work, Sanjin has formed strong professional and market advantages in throat, oral medication and urinary system medication. Its representative products, Sanjin Watermelon Cream Series and Sanjin Tablets, have been at the forefront of similar Chinese patent medicines in the country for many years. In July 2009, Guilin Sanjin successfully entered the capital market with a new look of high growth and high efficiency, and ushered in a new stage of rapid development of the enterprise. In recent years, in order to actively respond to the call of Guilin Municipal Party Committee and Municipal Government to "develop westward and create a new Guilin", and to resolve the contradiction between the dispersed production bases and warehousing facilities of enterprises and the rapid development of enterprises, Sanjin has launched the "Sanjin". The construction of the modern traditional Chinese medicine industrialization technology transformation project. At present, the first phase of the project has been officially put into production and the overall relocation of the main production lines has been achieved. Facing the future, Sanjin will uphold the corporate mission of "innovation to promote pharmaceutical progress" and the corporate spirit of "dare to be the first", implement the "one body and two wings" development strategy with traditional Chinese medicine as the main body and committed to developing biopharmaceuticals and the big health industry, Quality and reputation are the first life of the enterprise, breakthroughs and innovation, continuously enhances the competitive strength of Sanjin, and is enterprising, with the goal of developing to serve the country and repay investors, and with the goal of building China's advanced pharmaceutical manufacturing group, we will promote the modernization and internationalization of the traditional Chinese medicine industry!
NINGBO RAYCAREMED MEDICAL INSTRUMENTS CO., LTD
Ningbo Raycaremed Medical Instruments Co.,Ltd is one of the professional supplier for the Medical Instrument products in China. Our Team has more than 10 years experiences in Medical field. We export our products to customers in Europe, Africa, Asia and America. We are factory ,located in Jiangsu province,which near Shanghai port, we produce Syringe, infusion set, Gloves and Face mask.
In order to fulfill and increasing needs of our trusted and loyal customers,apart from our factory ,we have more than 5 strategic partners which produce urine bags, surgical gowns, medical tubes, wound dressing syringes diagnostics & lab products.
We care the success of our customers,we know that the important of quality,so we set up a strong QC team stay in differences production lines to ensure & control quality.
Our Company is approved by CE&ISO certificates for most of products.
In future, Raycaremed Medical will keep high effcient and professional for every customer, and associating company development with human health. We will keep putting love and respect into our every product all the way, and do our best effort to bring health to everyone at the world.
NINGBO RAYCAREMED MEDICAL INSTRUMENTS CO., LTD
Ningbo Raycaremed Medical Instruments Co.,Ltd is one of the professional supplier for the Medical Instrument products in China. Our Team has more than 10 years experiences in Medical field. We export our products to customers in Europe, Africa, Asia and America. We are factory ,located in Jiangsu province,which near Shanghai port, we produce Syringe, infusion set, Gloves and Face mask.
In order to fulfill and increasing needs of our trusted and loyal customers,apart from our factory ,we have more than 5 strategic partners which produce urine bags, surgical gowns, medical tubes, wound dressing syringes diagnostics & lab products.
We care the success of our customers,we know that the important of quality,so we set up a strong QC team stay in differences production lines to ensure & control quality.
Our Company is approved by CE&ISO certificates for most of products.
In future, Raycaremed Medical will keep high effcient and professional for every customer, and associating company development with human health. We will keep putting love and respect into our every product all the way, and do our best effort to bring health to everyone at the world.
Shanghai Shangyao Xinyi Pharmaceutical Co., Ltd.
Xinyi brand, founded in 1916, is currently 100% wholly-owned by Shanghai Pharmaceutical Group Co., Ltd. and is a larger industrial manufacturing enterprise under Shanghai Pharmaceutical Group. As a national pharmaceutical enterprise with a century-old history, Shangyao Xinyi mainly undertakes the social responsibilities of national drug emergency reserves, supporting the state and local governments to promote medical reform, and support social welfare undertakings. At present, Xinyi has become one of the industrial entities with a complete range of product varieties and dosage forms in China. It has 11 major industrial enterprises, 2 major commercial companies, 1 procurement center, a municipal R&D center, and 2 joint ventures, with product approval documents Nearly 1,000, involving 14 major therapeutic areas, covering 20 dosage forms, and there are 2 countries with Class I new drug varieties. There are 405 sales specifications (of which 149 varieties and 270 products have entered the newly issued basic medicine catalogue of the state, accounting for nearly half of the chemical basic medicine catalogue). On the basis of maintaining the competitive advantages of chemical preparations, Xinyi has established the leading position of microecological preparations in the country, as well as four special dosage forms: aerosols, eye drops, soft capsules, and slow-release preparations. In 2011, Peficon was selected as the "national standard strain" of microecological preparations and was awarded the US ATCC standard strain in 2016. Currently, it is applying for registration as an independent intellectual property product in the United States FDA. Since 1999, Xinyi has launched a large-scale public welfare activity "Millions of Citizens See Pudong and Xinyi", which has continued to promote science and health concepts for 19 years, with 520,000 beneficiaries.
Shanghai Shangyao Xinyi Pharmaceutical Co., Ltd.
Xinyi brand, founded in 1916, is currently 100% wholly-owned by Shanghai Pharmaceutical Group Co., Ltd. and is a larger industrial manufacturing enterprise under Shanghai Pharmaceutical Group. As a national pharmaceutical enterprise with a century-old history, Shangyao Xinyi mainly undertakes the social responsibilities of national drug emergency reserves, supporting the state and local governments to promote medical reform, and support social welfare undertakings. At present, Xinyi has become one of the industrial entities with a complete range of product varieties and dosage forms in China. It has 11 major industrial enterprises, 2 major commercial companies, 1 procurement center, a municipal R&D center, and 2 joint ventures, with product approval documents Nearly 1,000, involving 14 major therapeutic areas, covering 20 dosage forms, and there are 2 countries with Class I new drug varieties. There are 405 sales specifications (of which 149 varieties and 270 products have entered the newly issued basic medicine catalogue of the state, accounting for nearly half of the chemical basic medicine catalogue). On the basis of maintaining the competitive advantages of chemical preparations, Xinyi has established the leading position of microecological preparations in the country, as well as four special dosage forms: aerosols, eye drops, soft capsules, and slow-release preparations. In 2011, Peficon was selected as the "national standard strain" of microecological preparations and was awarded the US ATCC standard strain in 2016. Currently, it is applying for registration as an independent intellectual property product in the United States FDA. Since 1999, Xinyi has launched a large-scale public welfare activity "Millions of Citizens See Pudong and Xinyi", which has continued to promote science and health concepts for 19 years, with 520,000 beneficiaries.
Guizhou Hongyu Pharmaceutical Co., Ltd.
Guizhou Hongyu Pharmaceutical Co., Ltd. is a key enterprise in Guiyang National High-tech Industrial Development Zone. The Guizhou Provincial Science and Technology Commission has identified as a "high-tech enterprise" as a backbone enterprise in the pharmaceutical industry in Guizhou Province. Since its establishment, the company has always positioned its development as a combination of Guizhou's authentic Chinese medicinal materials resources with modern high-tech pharmaceutical technology. Dare to play Guizhou cards, be good at playing Guizhou cards, and effectively allocate resources. In recent years, the company's development has increased at a rate of 50%. In December 1999, with the approval of the Ministry of Foreign Trade and Economic Cooperation, the company was approved for self-operated import and export rights. The company is located in Guiyang National High-tech Industrial Development Zone, covering an area of 29,000 square meters, with a construction area of 8,812.9 square meters, and has a production line of capsules, aerosols and granules. It is also equipped with high-performance liquid chromatographs, dual-wavelength flying point scanners, ultraviolet rays, and visible spectrophotometers and other advanced precision detection instruments produced by Shimadzu Manufacturing in Japan. Currently, the company's main products on the market include "Qianli Gastrodia eucommia ulmoides capsules", "Jinhujian spray", "Baofukang foam agent", and "Single flavor Chinese medicine refined granule decoction". The product quality is stable and the efficacy is accurate. Among them: "Kenli Gastrodia eucommia ulmoides Capsules" and the new drug "Baofukang Foam" have entered the national basic medicine catalog, and "Kenli Gastrodia eucommia ulmoides Capsules" are listed as national traditional Chinese medicine protected varieties. "Baofukang Foaming Agent" was rated as a national key new product of the State Economic and Trade Commission in 1999. "3CT Technology Development Project for Single-flavor Chinese Medicine Refined Granules" is listed as a national high-tech industrialization promotion project. While further expanding the domestic market, the company actively explores foreign markets, raises funds through the capital market, accelerates the industrialization of high-tech achievements, continuously enhances the company's competitiveness, and strives to enter the ranks of advanced pharmaceutical companies in China.
Guizhou Hongyu Pharmaceutical Co., Ltd.
Guizhou Hongyu Pharmaceutical Co., Ltd. is a key enterprise in Guiyang National High-tech Industrial Development Zone. The Guizhou Provincial Science and Technology Commission has identified as a "high-tech enterprise" as a backbone enterprise in the pharmaceutical industry in Guizhou Province. Since its establishment, the company has always positioned its development as a combination of Guizhou's authentic Chinese medicinal materials resources with modern high-tech pharmaceutical technology. Dare to play Guizhou cards, be good at playing Guizhou cards, and effectively allocate resources. In recent years, the company's development has increased at a rate of 50%. In December 1999, with the approval of the Ministry of Foreign Trade and Economic Cooperation, the company was approved for self-operated import and export rights. The company is located in Guiyang National High-tech Industrial Development Zone, covering an area of 29,000 square meters, with a construction area of 8,812.9 square meters, and has a production line of capsules, aerosols and granules. It is also equipped with high-performance liquid chromatographs, dual-wavelength flying point scanners, ultraviolet rays, and visible spectrophotometers and other advanced precision detection instruments produced by Shimadzu Manufacturing in Japan. Currently, the company's main products on the market include "Qianli Gastrodia eucommia ulmoides capsules", "Jinhujian spray", "Baofukang foam agent", and "Single flavor Chinese medicine refined granule decoction". The product quality is stable and the efficacy is accurate. Among them: "Kenli Gastrodia eucommia ulmoides Capsules" and the new drug "Baofukang Foam" have entered the national basic medicine catalog, and "Kenli Gastrodia eucommia ulmoides Capsules" are listed as national traditional Chinese medicine protected varieties. "Baofukang Foaming Agent" was rated as a national key new product of the State Economic and Trade Commission in 1999. "3CT Technology Development Project for Single-flavor Chinese Medicine Refined Granules" is listed as a national high-tech industrialization promotion project. While further expanding the domestic market, the company actively explores foreign markets, raises funds through the capital market, accelerates the industrialization of high-tech achievements, continuously enhances the company's competitiveness, and strives to enter the ranks of advanced pharmaceutical companies in China.
Shaanxi Feng Wuchen Grand Pharmacy Pharmaceutical Factory Co., Ltd.
Qiankun Group is a traditional Chinese medicine health industry cluster area integrating R&D, pharmaceutical, commerce, chain, health care and medical care. Its headquarters is located at a national-level with beautiful scenery, distinct four seasons, rich products and innovative urban development modes as the theme. New District - Xixian New District, located at the junction of Xi'an and Xianyang cities, has convenient transportation and a superior geographical location. It is only ten minutes away from the airport and subway. The group practices the core values of "helping the world, saving people, serving the country, making authentic medicines, and being a kind enterprise", and is committed to providing high-quality and efficient medicines and health services to the society, constantly improving and strengthening the layout of the entire industrial chain of traditional Chinese medicine, and after years of development , has 5 wholly-owned subsidiaries, namely: Xianyang Human Aging and Hyperplasia Research Institute, Xianyang Feng Wuchen National Medical Center, Shaanxi Feng Wuchen Pharmaceutical Hall, Shaanxi Feng Wuchen Pharmaceutical Factory, Shaanxi Daqinling Industrial Co., Ltd. (Qiankun· Qinhan Hospital, Qiankun Yileyuan Health and Elderly Apartment, Qiankun Traditional Chinese Medicine Museum, supporting commercial and residential industries, etc.), so far, the group has completed the overall layout of the traditional Chinese medicine health industry. Professor Feng Wuchen, the founder of the group, has been engaged in the research and inheritance of traditional Chinese medicine culture. He has rich clinical practice experience and is quite accomplished in diagnosing the disease and conducting early intervention. "Health Career and Benefiting Mankind" is the lofty ideal of Qiankun people. After more than 20 years of development and innovation, Qiankun Group has basically formed a new pattern of pharmaceutical industry development with diversified products, networked markets, scientific management, and youthful teams. Adhering to the corporate spirit of "helping the world, saving people, serving the country, making authentic medicines, and being kind to the enterprise", in line with the corporate style of "pure business, pursuing business, innovation and responsibility", based on the implementation of the national "Belt and Road" strategy and the health of traditional Chinese medicine A major opportunity for industrial development, Qiankun Group is committed to building a first-class domestic and internationally renowned pharmaceutical and health industry group.
Shaanxi Feng Wuchen Grand Pharmacy Pharmaceutical Factory Co., Ltd.
Qiankun Group is a traditional Chinese medicine health industry cluster area integrating R&D, pharmaceutical, commerce, chain, health care and medical care. Its headquarters is located at a national-level with beautiful scenery, distinct four seasons, rich products and innovative urban development modes as the theme. New District - Xixian New District, located at the junction of Xi'an and Xianyang cities, has convenient transportation and a superior geographical location. It is only ten minutes away from the airport and subway. The group practices the core values of "helping the world, saving people, serving the country, making authentic medicines, and being a kind enterprise", and is committed to providing high-quality and efficient medicines and health services to the society, constantly improving and strengthening the layout of the entire industrial chain of traditional Chinese medicine, and after years of development , has 5 wholly-owned subsidiaries, namely: Xianyang Human Aging and Hyperplasia Research Institute, Xianyang Feng Wuchen National Medical Center, Shaanxi Feng Wuchen Pharmaceutical Hall, Shaanxi Feng Wuchen Pharmaceutical Factory, Shaanxi Daqinling Industrial Co., Ltd. (Qiankun· Qinhan Hospital, Qiankun Yileyuan Health and Elderly Apartment, Qiankun Traditional Chinese Medicine Museum, supporting commercial and residential industries, etc.), so far, the group has completed the overall layout of the traditional Chinese medicine health industry. Professor Feng Wuchen, the founder of the group, has been engaged in the research and inheritance of traditional Chinese medicine culture. He has rich clinical practice experience and is quite accomplished in diagnosing the disease and conducting early intervention. "Health Career and Benefiting Mankind" is the lofty ideal of Qiankun people. After more than 20 years of development and innovation, Qiankun Group has basically formed a new pattern of pharmaceutical industry development with diversified products, networked markets, scientific management, and youthful teams. Adhering to the corporate spirit of "helping the world, saving people, serving the country, making authentic medicines, and being kind to the enterprise", in line with the corporate style of "pure business, pursuing business, innovation and responsibility", based on the implementation of the national "Belt and Road" strategy and the health of traditional Chinese medicine A major opportunity for industrial development, Qiankun Group is committed to building a first-class domestic and internationally renowned pharmaceutical and health industry group.
Guangdong Jiaying Pharmaceutical Co., Ltd.
Guangdong Jiaying Pharmaceutical Co., Ltd. is a Chinese patent medicine pharmaceutical company integrating R&D, production and sales. The company was established in 2003 by the restructuring of Meizhou Pharmaceutical Factory in Guangdong Province. In December 2007, it was listed on the Shenzhen Stock Exchange. Stock abbreviation: Jiaying Pharmaceutical, stock code: 002198. At present, the company has two drug research and development, production and sales bases in Changsha City, Hunan Province and Meizhou City, Guangdong Province, with a total assets of more than 1 billion yuan and a total market value of nearly 3 billion yuan. The company has a total of 5 dosage forms and 70 drug approval numbers. The products include throat, cold, orthopedics, rheumatology, gynecology, heat clearance, nourishing, and gastrointestinal. The main products include Shuangliu Fengsan, Chonggui Ling tablet, Qiliu tablet (capsule), Shufenghuluo tablet, Menstrual regulation and blood circulation tablet, etc. Among them, Shuangliu Fengsan is developed using a century-old formula and is used in pharyngeal medicine. It has a high reputation and reputation and is very popular among consumers. The company has set up marketing offices in 30 provincial capital cities across the country and has established relatively stable cooperative relationships with thousands of pharmaceutical companies and more than 2,000 medical institutions. The company currently has more than 90 scientific and technological personnel and more than 1,000 production and sales employees. It has established a collaborative innovation cooperation relationship with many universities and research institutes. It has strong R&D capabilities in new products and is in the industry. front end. The type value of traditional Chinese medicine raw materials, the scale and technological content of the extraction and deep processing projects are industry benchmarks and are of great strategic significance for the development of the international market.
Guangdong Jiaying Pharmaceutical Co., Ltd.
Guangdong Jiaying Pharmaceutical Co., Ltd. is a Chinese patent medicine pharmaceutical company integrating R&D, production and sales. The company was established in 2003 by the restructuring of Meizhou Pharmaceutical Factory in Guangdong Province. In December 2007, it was listed on the Shenzhen Stock Exchange. Stock abbreviation: Jiaying Pharmaceutical, stock code: 002198. At present, the company has two drug research and development, production and sales bases in Changsha City, Hunan Province and Meizhou City, Guangdong Province, with a total assets of more than 1 billion yuan and a total market value of nearly 3 billion yuan. The company has a total of 5 dosage forms and 70 drug approval numbers. The products include throat, cold, orthopedics, rheumatology, gynecology, heat clearance, nourishing, and gastrointestinal. The main products include Shuangliu Fengsan, Chonggui Ling tablet, Qiliu tablet (capsule), Shufenghuluo tablet, Menstrual regulation and blood circulation tablet, etc. Among them, Shuangliu Fengsan is developed using a century-old formula and is used in pharyngeal medicine. It has a high reputation and reputation and is very popular among consumers. The company has set up marketing offices in 30 provincial capital cities across the country and has established relatively stable cooperative relationships with thousands of pharmaceutical companies and more than 2,000 medical institutions. The company currently has more than 90 scientific and technological personnel and more than 1,000 production and sales employees. It has established a collaborative innovation cooperation relationship with many universities and research institutes. It has strong R&D capabilities in new products and is in the industry. front end. The type value of traditional Chinese medicine raw materials, the scale and technological content of the extraction and deep processing projects are industry benchmarks and are of great strategic significance for the development of the international market.
Guangzhou Fuerle Health Technology Co., Ltd
Guangzhou Fuerle Health Technology Co., Ltd. has been focusing on the R&D and production of intelligent beauty and health products, sub-health repair and conditioning equipment for 20 years.
The company conducts cooperative research projects with the Academy of Chinese Academy of Sciences, the School of Psychology of South China Normal University, the Institute of Life Sciences of Sun Yat-sen University, and the School of Tibetan Medicine of Qinghai University.
The company has obtained CE, CB, FCC, UKCA, PSE, SAA, RoHS, FDA, ISO9001, CCC and other certifications, and has more than 100 product invention patents, appearance patents and practical patents. The products are exclusively for domestic and foreign e-commerce, Beauty and health care offline entities, brand owners, project companies and other channels are exported to more than 100 countries in Southeast Asia, Europe and the United States.
Main products: Graphene, far-infrared products, photon pemf mat, sauna dome, infrared sauna blankets, body slimming belts and other health and intelligent beauty care products.
Guangzhou Fuerle Health Technology Co., Ltd
Guangzhou Fuerle Health Technology Co., Ltd. has been focusing on the R&D and production of intelligent beauty and health products, sub-health repair and conditioning equipment for 20 years.
The company conducts cooperative research projects with the Academy of Chinese Academy of Sciences, the School of Psychology of South China Normal University, the Institute of Life Sciences of Sun Yat-sen University, and the School of Tibetan Medicine of Qinghai University.
The company has obtained CE, CB, FCC, UKCA, PSE, SAA, RoHS, FDA, ISO9001, CCC and other certifications, and has more than 100 product invention patents, appearance patents and practical patents. The products are exclusively for domestic and foreign e-commerce, Beauty and health care offline entities, brand owners, project companies and other channels are exported to more than 100 countries in Southeast Asia, Europe and the United States.
Main products: Graphene, far-infrared products, photon pemf mat, sauna dome, infrared sauna blankets, body slimming belts and other health and intelligent beauty care products.
Changzhou Weipu Medical Devices Co., Ltd.
Changzhou Weipu Medical Devices Co., Ltd. is located in Xinbei District Changzhou City, in the Golden Triangle of the Yangtze River, here we have superior geographical location and convenient transportation.The company covers an area of over 20000 square meters and is dedicated to the research and development, production, sales, and service of medical devices.
As one of the largest OEM manufacturer in China, we achieve full inspection of each product and specification, with a large workload every time. We have a strong commitment to healthcare professionals, and we are proving it every day. Although it is time-consuming and labor-intensive, and increases costs, the quality reputation of Weipu brand has won recognition from the market and customers.
Our company adheres to the corporate philosophy of "customer first, technological innovation, reliable quality", and has a large number of professional talents, laying a solid foundation for the company to continuously surpass and pursue better goals. The company actively follows the ISO13485 quality management system, strictly manages quality, ensures product quality, provides trustworthy products for users, and receives recognition from the majority of users with the most thoughtful service.
Healthcare professionals inspire our wound management, prevention and surgical solutions. Their relentless search for new and better ways to care for patients drives us to innovate. And the research and development of new products is the source of maintaining a company's market advantage and competitiveness. Therefore, we always insist on paying tribute to life with innovation, patient safety first and clinical effect first.
Changzhou Weipu Medical Devices Co., Ltd.
Changzhou Weipu Medical Devices Co., Ltd. is located in Xinbei District Changzhou City, in the Golden Triangle of the Yangtze River, here we have superior geographical location and convenient transportation.The company covers an area of over 20000 square meters and is dedicated to the research and development, production, sales, and service of medical devices.
As one of the largest OEM manufacturer in China, we achieve full inspection of each product and specification, with a large workload every time. We have a strong commitment to healthcare professionals, and we are proving it every day. Although it is time-consuming and labor-intensive, and increases costs, the quality reputation of Weipu brand has won recognition from the market and customers.
Our company adheres to the corporate philosophy of "customer first, technological innovation, reliable quality", and has a large number of professional talents, laying a solid foundation for the company to continuously surpass and pursue better goals. The company actively follows the ISO13485 quality management system, strictly manages quality, ensures product quality, provides trustworthy products for users, and receives recognition from the majority of users with the most thoughtful service.
Healthcare professionals inspire our wound management, prevention and surgical solutions. Their relentless search for new and better ways to care for patients drives us to innovate. And the research and development of new products is the source of maintaining a company's market advantage and competitiveness. Therefore, we always insist on paying tribute to life with innovation, patient safety first and clinical effect first.
Guizhou Sanli Pharmaceutical Co., Ltd.
Guizhou Sanli Pharmaceutical Co., Ltd. was established in 1995. It is a modern Chinese patent medicine pharmaceutical enterprise integrating R&D, production and sales. The company's product line mainly focuses on pediatrics, respiratory, cardiovascular and cerebrovascular, gastroenterology and other fields. The main products are open throat sword spray (children type), open throat sword spray and strong Gastrodia eucommia capsules. Among them, the core products of the open throat sword spray (children type) and the open throat sword spray are both national patented products, occupying a high market share in the market of Chinese patent medicine spray for throat diseases, and have been in the fields of Chinese patent medicine for throat diseases and children. A certain brand awareness has been formed. Since its establishment, Guizhou Sanli has always adhered to the quality policy of quality first, abiding by reputation and dedicated service, and has taken the new version of GMP as the minimum control standard, striving for excellence and continuous improvement. In the future, Guizhou Sanli will continue to adhere to the development of traditional Chinese patent medicines as the core, inherit the excellent historical and cultural traditions of traditional Chinese medicine, and continuously promote classic prescriptions such as traditional Chinese medicine, ethnic medicine, and Miao medicine. For the current frequent disease types, relying on the technical concept of modernizing traditional Chinese medicine. , with the goal of continuously improving product quality and user experience, we are committed to becoming the leader in segmented fields. Adhering to the corporate mission of "creating a healthy life for human beings", we will move towards the vision of "becoming a pharmaceutical company trusted by the Chinese people", and with practical actions, we will fulfill our commitment to steady development in the entire pharmaceutical and health industry.
Guizhou Sanli Pharmaceutical Co., Ltd.
Guizhou Sanli Pharmaceutical Co., Ltd. was established in 1995. It is a modern Chinese patent medicine pharmaceutical enterprise integrating R&D, production and sales. The company's product line mainly focuses on pediatrics, respiratory, cardiovascular and cerebrovascular, gastroenterology and other fields. The main products are open throat sword spray (children type), open throat sword spray and strong Gastrodia eucommia capsules. Among them, the core products of the open throat sword spray (children type) and the open throat sword spray are both national patented products, occupying a high market share in the market of Chinese patent medicine spray for throat diseases, and have been in the fields of Chinese patent medicine for throat diseases and children. A certain brand awareness has been formed. Since its establishment, Guizhou Sanli has always adhered to the quality policy of quality first, abiding by reputation and dedicated service, and has taken the new version of GMP as the minimum control standard, striving for excellence and continuous improvement. In the future, Guizhou Sanli will continue to adhere to the development of traditional Chinese patent medicines as the core, inherit the excellent historical and cultural traditions of traditional Chinese medicine, and continuously promote classic prescriptions such as traditional Chinese medicine, ethnic medicine, and Miao medicine. For the current frequent disease types, relying on the technical concept of modernizing traditional Chinese medicine. , with the goal of continuously improving product quality and user experience, we are committed to becoming the leader in segmented fields. Adhering to the corporate mission of "creating a healthy life for human beings", we will move towards the vision of "becoming a pharmaceutical company trusted by the Chinese people", and with practical actions, we will fulfill our commitment to steady development in the entire pharmaceutical and health industry.
Guangzhou Baiyunshan Qixing Pharmaceutical Co., Ltd.
Guangzhou Baiyunshan Qixing Pharmaceutical Co., Ltd. is affiliated to Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. and is a key subsidiary of Guangzhou Pharmaceutical Group. The company has a history of more than 140 years. It owns two major trademarks: "Baiyun Mountain" and "Qixing". The company has a product structure that mainly cardiovascular drugs and pediatric drugs as the auxiliary products. It has six dosage forms: pills, tablets, capsules, granules, powders, and mixtures, and its products are sold at home and abroad markets. Among them, Huatuo Rezai Pills are included in the National Medical Insurance Class A catalog and the National Basic Drug Catalog. They are also the product with a large export volume of a single variety of Chinese patent medicines in my country. The company follows the business philosophy of "Guangyao Qixing, Pharmaceuticals seeking excellence", adheres to the corporate spirit of "unity, pioneering, realistic, efficient, moral integrity, trustworthiness, innovation, and harmony", and shines in the history of the development of traditional Chinese medicine. The company has been constantly exploring the internationalization of traditional Chinese medicine for many years, creating the Huatuo Remade Pill Model of "making the world in line with traditional Chinese medicine", providing a reference for the internationalization of traditional Chinese medicine for domestic enterprises. Hua Tuo Rezao Pills have entered the world as a drug, exported to 29 countries and regions including Russia and Vietnam, and entered the Vietnamese national medical insurance drug catalog and obtained a permanent approval for Russian drug registration, successfully entering the international mainstream market for cardiovascular and cerebrovascular disease prevention and treatment drugs.
Guangzhou Baiyunshan Qixing Pharmaceutical Co., Ltd.
Guangzhou Baiyunshan Qixing Pharmaceutical Co., Ltd. is affiliated to Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. and is a key subsidiary of Guangzhou Pharmaceutical Group. The company has a history of more than 140 years. It owns two major trademarks: "Baiyun Mountain" and "Qixing". The company has a product structure that mainly cardiovascular drugs and pediatric drugs as the auxiliary products. It has six dosage forms: pills, tablets, capsules, granules, powders, and mixtures, and its products are sold at home and abroad markets. Among them, Huatuo Rezai Pills are included in the National Medical Insurance Class A catalog and the National Basic Drug Catalog. They are also the product with a large export volume of a single variety of Chinese patent medicines in my country. The company follows the business philosophy of "Guangyao Qixing, Pharmaceuticals seeking excellence", adheres to the corporate spirit of "unity, pioneering, realistic, efficient, moral integrity, trustworthiness, innovation, and harmony", and shines in the history of the development of traditional Chinese medicine. The company has been constantly exploring the internationalization of traditional Chinese medicine for many years, creating the Huatuo Remade Pill Model of "making the world in line with traditional Chinese medicine", providing a reference for the internationalization of traditional Chinese medicine for domestic enterprises. Hua Tuo Rezao Pills have entered the world as a drug, exported to 29 countries and regions including Russia and Vietnam, and entered the Vietnamese national medical insurance drug catalog and obtained a permanent approval for Russian drug registration, successfully entering the international mainstream market for cardiovascular and cerebrovascular disease prevention and treatment drugs.
Xuzhou Kailier Sauna Equipment CO.,LTD
**Company Background and History**
Xuzhou Kailier Sauna Equipment Co., Ltd. was established in 1995, specializing in the research, development and production of far-infrared sauna products, with nearly 30 years of experience in the industry. The company was founded by a well-known local furniture craftsman. With a deep understanding of product structure and appearance design, Kelier has gradually grown into a comprehensive enterprise integrating R&D, production and sales.
Over the years, we have improved our management level and production efficiency through systematization and informationization. Our customers are all over East Asia, Europe and America, and we have successfully penetrated into high standard markets such as Germany and Japan. Currently, our export share is mainly concentrated in Germany (50%), the United States (30%), South Korea (10%), and other markets account for 10%.
**Capacity and Market Adjustment**
Kailier has excellent production capacity, especially in the far-infrared footbath production line, with a monthly capacity of 12,000-15,000 units, mainly supplying the Korean market. Due to the recent economic downturn in the market leading to a decrease in orders, the company has decided to shift part of the production capacity of the footbath bucket production line to the pet product market in order to fill the capacity gap.
**Pet Product Development**
Kailier has systematically built its R&D team since 2013, focusing on new product development and technological innovation. The company has an advanced production management system, introduced MRP II type production management mode as early as 2014, and independently developed production management system to realize high efficiency production, accurate delivery prediction and smooth production flow. The monthly production capacity can reach 1,500-2,000 saunas (about 30 containers), and 12,000-15,000 footbath buckets or pet products. In recent years, the company has also introduced a number of automated and intelligent production equipment, which has significantly improved production efficiency and product quality.
**Department structure and Team**
Kailier has a perfect organizational structure, the coordinated operation of all departments to ensure efficient production and strict quality control of products:
【Foreign Trade Department and Domestic Trade Department】：Responsible for the development and maintenance of international and domestic markets respectively.
【Production Department】：Responsible for production planning and manufacturing process to ensure efficient operation.
[Follow-up Department]: Manage orders and customer communication to ensure accurate order processing and customer satisfaction.
【Quality Department】：Including 7 quality control professionals, responsible for product quality control and testing.
【Engineering Department】：Including 2 electrical engineers, 1 BOM engineer and 3 engineering structural engineers, responsible for product development and technical support.
【Incoming Material Inspection】: Strictly control the quality of raw materials.
【Design Department】: including 1 3D design engineer and 1 graphic designer, responsible for product appearance design and visual image.
【Documentation Department】: 1 single certificate specialist, responsible for the management of export-related documents.
【Capital & Finance Department】: Responsible for the company's financial management and resource planning to ensure financial health and rational allocation of resources to support the company's sustainable development.
**Informatization management and quality control**
The company adopts advanced ERP system for comprehensive management, covering all aspects of purchasing, production, sales, inventory and finance, ensuring real-time sharing of information and efficient operation of management. In terms of quality control, the company is equipped with large-scale experimental and testing equipment, and implements strict multiple inspection methods to ensure that the appearance and reliability of the products meet the high standards of the industry.
Xuzhou Kailier Sauna Equipment CO.,LTD
**Company Background and History**
Xuzhou Kailier Sauna Equipment Co., Ltd. was established in 1995, specializing in the research, development and production of far-infrared sauna products, with nearly 30 years of experience in the industry. The company was founded by a well-known local furniture craftsman. With a deep understanding of product structure and appearance design, Kelier has gradually grown into a comprehensive enterprise integrating R&D, production and sales.
Over the years, we have improved our management level and production efficiency through systematization and informationization. Our customers are all over East Asia, Europe and America, and we have successfully penetrated into high standard markets such as Germany and Japan. Currently, our export share is mainly concentrated in Germany (50%), the United States (30%), South Korea (10%), and other markets account for 10%.
**Capacity and Market Adjustment**
Kailier has excellent production capacity, especially in the far-infrared footbath production line, with a monthly capacity of 12,000-15,000 units, mainly supplying the Korean market. Due to the recent economic downturn in the market leading to a decrease in orders, the company has decided to shift part of the production capacity of the footbath bucket production line to the pet product market in order to fill the capacity gap.
**Pet Product Development**
Kailier has systematically built its R&D team since 2013, focusing on new product development and technological innovation. The company has an advanced production management system, introduced MRP II type production management mode as early as 2014, and independently developed production management system to realize high efficiency production, accurate delivery prediction and smooth production flow. The monthly production capacity can reach 1,500-2,000 saunas (about 30 containers), and 12,000-15,000 footbath buckets or pet products. In recent years, the company has also introduced a number of automated and intelligent production equipment, which has significantly improved production efficiency and product quality.
**Department structure and Team**
Kailier has a perfect organizational structure, the coordinated operation of all departments to ensure efficient production and strict quality control of products:
【Foreign Trade Department and Domestic Trade Department】：Responsible for the development and maintenance of international and domestic markets respectively.
【Production Department】：Responsible for production planning and manufacturing process to ensure efficient operation.
[Follow-up Department]: Manage orders and customer communication to ensure accurate order processing and customer satisfaction.
【Quality Department】：Including 7 quality control professionals, responsible for product quality control and testing.
【Engineering Department】：Including 2 electrical engineers, 1 BOM engineer and 3 engineering structural engineers, responsible for product development and technical support.
【Incoming Material Inspection】: Strictly control the quality of raw materials.
【Design Department】: including 1 3D design engineer and 1 graphic designer, responsible for product appearance design and visual image.
【Documentation Department】: 1 single certificate specialist, responsible for the management of export-related documents.
【Capital & Finance Department】: Responsible for the company's financial management and resource planning to ensure financial health and rational allocation of resources to support the company's sustainable development.
**Informatization management and quality control**
The company adopts advanced ERP system for comprehensive management, covering all aspects of purchasing, production, sales, inventory and finance, ensuring real-time sharing of information and efficient operation of management. In terms of quality control, the company is equipped with large-scale experimental and testing equipment, and implements strict multiple inspection methods to ensure that the appearance and reliability of the products meet the high standards of the industry.
YATTLL Industry Co., Ltd was founded in 2017, as one of the many subsidiaries of YALU Industry Group, YATTLL is the proprietary brand of medical products.YATTLL`s product line includes two major directions: Smart travel and Rehabilitation assistance.
YATTLL Industry Co., Ltd
YATTLL Industry Co., Ltd was founded in 2017, as one of the many subsidiaries of YALU Industry Group, YATTLL is the proprietary brand of medical products.YATTLL`s product line includes two major directions: Smart travel and Rehabilitation assistance.
Ricola is a well-known manufacturer of throat and mints in Switzerland. The company was established in 1930, and its headquarters was established in the Swiss city of Lefen, emphasizing the natural herbal materials used during production. Swiss Liqueur Natural Vanilla Sugar, unique flavor and refreshing and moisturizing. In order to cater to different consumers' preferences, Liqueur is also available in original flavors, lemon and extra strong mint for choice. In the early 1980s, Hong Kong Liquor Mint Advertising invited the well-known Cantonese film The Gang Kao Shi Jian to perform, successfully creating the image of "the traitor has its own tricks" for the brand, which was deeply rooted in the hearts of the people. In order to maintain a clear voice, the well-known king Michael Jackson usually adds two drops of Ricola to a cup of hot water before drinking it.
DKSH Hong Kong Limited
Ricola is a well-known manufacturer of throat and mints in Switzerland. The company was established in 1930, and its headquarters was established in the Swiss city of Lefen, emphasizing the natural herbal materials used during production. Swiss Liqueur Natural Vanilla Sugar, unique flavor and refreshing and moisturizing. In order to cater to different consumers' preferences, Liqueur is also available in original flavors, lemon and extra strong mint for choice. In the early 1980s, Hong Kong Liquor Mint Advertising invited the well-known Cantonese film The Gang Kao Shi Jian to perform, successfully creating the image of "the traitor has its own tricks" for the brand, which was deeply rooted in the hearts of the people. In order to maintain a clear voice, the well-known king Michael Jackson usually adds two drops of Ricola to a cup of hot water before drinking it.
Mucinex offers a range of cold and flu remedies, including pediatric formulations for cough and congestion.
Reckitt Benckiser
Mucinex offers a range of cold and flu remedies, including pediatric formulations for cough and congestion.
A leading homeopathic brand offering herbal products, including licorice and dried ginger formulations.
Boiron
A leading homeopathic brand offering herbal products, including licorice and dried ginger formulations.
Siping Vickers Heat Exchange Equipment Co., Ltd.
China Siping Vickers Heat Exchange Equipment Co., Ltd. is a core member unit of Vickers International Group. It is currently one of the largest and most comprehensive professional manufacturing companies for heat exchange equipment in Asia. The design, manufacturing and R&D base of Vickers International Group is composed of branches with regional centers such as France, the United States, and Singapore, and its sales service network is spread all over the world. Integrating international advanced technology, Viex Group continues to innovate, and now ViEX has become a world-renowned manufacturer of heat exchange equipment. Over the past few decades, from Siping Heat Exchanger Factory to Siping Vickers Company, it has developed leap forward and bigger and stronger. The current garden-style factory covers an area of 60,000 square meters and has a construction area of 26,000 square meters. In 2004, after introducing the complete set of French fine molds and production processes, it has been continuously improved and optimized. Now we have 310 sets of various production, processing and inspection equipment. There are 460 fixed employees in the enterprise. Among them, scientific and technological personnel account for about 50% of the total number of employees. With the completion of the renovation of the old industrial base project in Northeast China, the company has expanded its production scale and capacity. Business scope Heat exchange equipment, environmental protection equipment and their edge products design, manufacturing, and sales; import and export of goods; import and export of technology and their agents. Corporate capabilities It produces 200,000 square meters and 4,000 sets (sets) of various heat exchange equipment annually. Annual sales of RMB 300 million, of which exports earn US$10 million.
Siping Vickers Heat Exchange Equipment Co., Ltd.
China Siping Vickers Heat Exchange Equipment Co., Ltd. is a core member unit of Vickers International Group. It is currently one of the largest and most comprehensive professional manufacturing companies for heat exchange equipment in Asia. The design, manufacturing and R&D base of Vickers International Group is composed of branches with regional centers such as France, the United States, and Singapore, and its sales service network is spread all over the world. Integrating international advanced technology, Viex Group continues to innovate, and now ViEX has become a world-renowned manufacturer of heat exchange equipment. Over the past few decades, from Siping Heat Exchanger Factory to Siping Vickers Company, it has developed leap forward and bigger and stronger. The current garden-style factory covers an area of 60,000 square meters and has a construction area of 26,000 square meters. In 2004, after introducing the complete set of French fine molds and production processes, it has been continuously improved and optimized. Now we have 310 sets of various production, processing and inspection equipment. There are 460 fixed employees in the enterprise. Among them, scientific and technological personnel account for about 50% of the total number of employees. With the completion of the renovation of the old industrial base project in Northeast China, the company has expanded its production scale and capacity. Business scope Heat exchange equipment, environmental protection equipment and their edge products design, manufacturing, and sales; import and export of goods; import and export of technology and their agents. Corporate capabilities It produces 200,000 square meters and 4,000 sets (sets) of various heat exchange equipment annually. Annual sales of RMB 300 million, of which exports earn US$10 million.
